查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1654684

全球食道镜和胃镜市场 - 2025 至 2033 年

Global Esophagoscopes and Gastroscopes Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 153 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球食道镜和胃镜市场规模达到 18 亿美元，预计到 2033 年将达到 29 亿美元，2025-2033 年预测期内的复合年增长率为 5.6%。

食道镜是用于检查食道（连接喉咙和胃的管道）的专门内视镜仪器。这些设备用于诊断食道疾病，例如胃酸逆流症 (GERD)、食道癌、食道狭窄和异物取出。食道镜可以是刚性的，也可以是柔性的，其中柔性食道镜由于其能够弯曲并舒适地穿过食道而更常用。

胃镜是用来检查胃和小肠上部的内视镜仪器。这些设备对于诊断和治疗胃炎、消化性溃疡、胃癌和幽门螺旋桿菌感染等疾病至关重要。与食道镜类似，胃镜可为硬式或软式，其中软式胃镜因可轻鬆进入胃及十二指肠的各个部位而得到更广泛的应用。

食道镜和胃镜的需求受到多种关键因素的推动，包括胃肠道 (GI) 疾病盛行率的不断上升、内视镜技术的进步以及医疗保健投资的不断增长。胃炎、消化性溃疡、胃食道逆流症 (GERD)、食道癌和胃癌以及其他胃肠道疾病等胃肠道疾病发病率的增加大大增加了对诊断和治疗内视镜手术的需求。例如，在最近一项在33个国家进行的全球研究中，作者发现全世界超过40%的人患有胃肠道疾病，发展中国家的盛行率更高。

市场动态：

驱动因素与约束因素

一次性食道镜和胃镜的采用率不断上升

一次性食道镜和胃镜的日益普及极大地推动了食道镜和胃镜市场的成长，预计将在预测期内推动市场的发展。 COVID-19 疫情提高了人们对医疗保健环境中感染预防的关注，尤其是在交叉污染风险较高的内视镜检查过程中。如果没有正确消毒，可重复使用的食道镜和胃镜可能会带来严重的健康风险，包括传播医院内感染（HAI）。由于医院和医疗保健提供者将病患安全放在首位，对一次性食道镜和胃镜的偏好日益增加，导致市场采用率不断增长。

例如，2024 年 7 月，EvoEndo, Inc. 发布了型号 LE 85 一次性胃镜，为上消化道无镇静经鼻内视镜检查 (TNE) 提供了另一种选择。 LE 85 型一次性胃镜旨在当不需要进入十二指肠时提供最佳的患者舒适度和医生控制。它的轴长更短，灵活性更高，能够确保患者的安全。

随着患者和医生继续青睐恢復时间更快、併发症发生率更低的微创手术，一次性内视镜的需求正在上升。这些设备支援具有下一代功能的各种诊断和治疗程序，同时还提供安全性和易用性的额外优势。这些一次性设备使医生能够满足医院环境、重症监护室和内视镜科的更大需求。

例如，2024 年 4 月，Ambu 宣布其治疗性胃镜解决方案 Ambu aScope Gastro Large 和 Ambu aBox 2 已获得美国食品药物管理局 (FDA) 的 510(k) 监管批准。扩展的内视镜产品组合，包括 aScope Gastro 和 aScope Gastro Large，使医生能够满足医院环境中（例如手术室、重症监护室和内视镜室）的更多种类的需求。

来自替代诊断技术的竞争

虽然食道镜和胃镜对于诊断和治疗胃肠道 (GI) 疾病仍然至关重要，但来自替代诊断技术的竞争对市场的成长构成了越来越大的挑战。这些替代方案通常提供非侵入性、经济高效且对患者侵入性较小的选择，可与传统内视镜检查程序相媲美。

CT 扫描 (电脑断层扫描)、MRI (磁振造影) 和超音波等非侵入性影像技术作为传统内视镜手术的替代方案，正日益受到关注。这些影像方法使医生无需进行侵入性手术即可诊断胃肠道疾病，从而降低了併发症的风险并提高了患者的舒适度。 CT大肠造影（虚拟大肠镜检查）由于其手术时间更短、患者不适感更少而越来越受到人们的认可。

胶囊内视镜检查是将一个小型相机以药丸的形式送入患者体内，作为一种检查小肠的传统内视镜检查的非侵入性替代方法，正越来越受欢迎。这种方法使医生无需使用食道镜或胃镜即可观察胃肠道，特别是在不明原因的胃肠道出血或小肠疾病的情况下。例如，据美敦力公司称，胶囊内视镜市场（如PillCam系统）正在成长，特别是在北美和欧洲等地区。这阻碍了对食道镜和胃镜的需求。

目录

第一章：市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 依产品类型分类的片段
  • 可用性片段
  • 按应用程式截取的程式码片段
  • 最终用户的程式码片段
  • 按地区分类的片段

第 3 章：动态

  • 影响因素
    • 驱动程式
      • 一次性食道镜和胃镜的普及率不断上升
    • 限制
      • 来自替代诊断技术的竞争
    • 机会
    • 影响分析

第四章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • 新兴创业公司和关键创新者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：食道镜和胃镜市场（依产品类型）

  • 食道镜
    • 硬质食道镜
    • 柔性食道镜
    • 经鼻食道镜
    • 纤维食道镜
  • 胃镜
    • 硬式胃镜
    • 柔性胃镜
    • 经鼻胃镜
    • 电子胃镜

第 6 章：食道镜和胃镜市场（按可用性划分）

  • 一次性的
  • 可重复使用的

第 7 章：食道镜和胃镜市场（按应用）

  • 食道疾病
  • 胃病
  • 食道癌及胃癌检测
  • 胃组织切片
  • 食道支架手术
  • 其他的

第 8 章：食道镜和胃镜市场（按最终用户划分）

  • 医院
  • 专科诊所
  • 诊断中心
  • 门诊手术中心
  • 其他的

第 9 章：食道镜和胃镜市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章：公司简介

  • Olympus Corporation
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 关键进展
    • SWOT 分析
  • FUJIFILM Holdings Corporation
  • Ambu A/S
  • EvoEndo, Inc.
  • EndoMed Systems GmbH
  • Ottomed Endoscopy
  • KARL STORZ
  • Integra LifeSciences Corporation
  • PENTAX Medical
  • Erbe Elektromedizin GmbH

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: MI9130

The global esophagoscopes and gastroscopes market reached US$ 1.8 billion in 2024 and is expected to reach US$ 2.9 billion by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.

Esophagoscopes are specialized endoscopic instruments used to examine the esophagus, which is the tube that connects the throat to the stomach. These devices are utilized for diagnosing esophageal disorders, such as acid reflux disease (GERD), esophageal cancer, esophageal stricture and foreign body removal. Esophagoscopes can be either rigid or flexible, with flexible esophagoscopes being more commonly used due to their ability to bend and navigate the esophagus comfortably.

Gastroscopes are endoscopic instruments used to examine the stomach and the upper part of the small intestine. These devices are crucial for diagnosing and treating conditions such as gastritis, peptic ulcers, gastric cancers, and H. pylori infection. Similar to esophagoscopes, gastroscopes can be rigid or flexible, with flexible gastroscopes being more widely adopted due to their ability to access various parts of the stomach and the duodenum with ease.

The demand for esophagoscopes and gastroscopes is driven by several key factors, including the increasing prevalence of gastrointestinal (GI) disorders, advancements in endoscopic technology and growing healthcare investments. The increased incidence of gastrointestinal diseases such as gastritis, peptic ulcers, gastroesophageal reflux disease (GERD), esophageal and stomach cancers and other GI disorders significantly fuels the demand for diagnostic and therapeutic endoscopic procedures. For instance, in a recent global study conducted in 33 countries, the authors found that more than 40% of people worldwide have gastrointestinal disorders with higher prevalence in developing countries.

Market Dynamics: Drivers & Restraints

Rising adoption of disposable esophagoscopes and gastroscopes

The rising adoption of disposable esophagoscopes and gastroscopes is significantly driving the growth of the esophagoscopes and gastroscopes market and is expected to drive the market over the forecast period. The COVID-19 pandemic heightened the focus on infection prevention within healthcare settings, especially in endoscopic procedures, where the risk of cross-contamination is high. Reusable esophagoscopes and gastroscopes, if not properly sterilized, can pose serious health risks, including the transmission of hospital-acquired infections (HAIs). The rising preference for disposable esophagoscopes and gastroscopes has led to growing market adoption as hospitals and healthcare providers prioritize patient safety.

For instance, in July 2024, EvoEndo, Inc. released the Model LE 85 Single-Use Gastroscope, providing an additional option for Sedation-Free Transnasal Endoscopy (TNE) of the Upper Gastrointestinal Tract. The Model LE 85 Single-Use Gastroscope is intended to provide optimal patient comfort and physician control when access to the duodenum is not necessary. It has a shorter shaft length and more flexibility for patient safety.

As patients and physicians continue to favor minimally invasive procedures that offer faster recovery times and reduced complication rates, the demand for single-use endoscopes is on the rise. These devices support a variety of diagnostic and therapeutic procedures with next-generation features while offering the added benefit of safety and ease of use. These disposable devices enables doctors to address a larger demands in hospital settings, critical care unit and endoscopic unit.

For instance, in April 2024, Ambu announced 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its therapeutic gastroscope solution, Ambu aScope Gastro Large and Ambu aBox 2. The approval represents an expanded solution offering for surgeons and gastroenterologists who undertake upper GI operations. The expanded endoscope portfolio, including the aScope Gastro and aScope Gastro Large, enables doctors to address a larger variety of demands in hospital settings such as the operating room, critical care unit and endoscopic unit.

Competition from alternative diagnostic technologies

While esophagoscopes and gastroscopes remain crucial for diagnosing and treating gastrointestinal (GI) disorders, the competition from alternative diagnostic technologies is increasingly presenting challenges to the growth of the market. These alternatives often offer non-invasive, cost-effective, and less patient-invasive options that compete with traditional endoscopy procedures.

Non-invasive imaging techniques, such as CT scans (computed tomography), MRI (magnetic resonance imaging) and ultrasound are gaining traction as alternatives to traditional endoscopic procedures. These imaging methods allow physicians to diagnose gastrointestinal conditions without the need for invasive procedures, reducing the risks of complications and improving patient comfort. CT Colonography (Virtual Colonoscopy) is increasingly gaining acceptance due to its shorter procedure time and less patient discomfort.

Capsule endoscopy, where a small camera is ingested by the patient in the form of a pill, is gaining popularity as a non-invasive alternative to traditional endoscopies for examining the small intestine. This method allows physicians to view the GI tract without the need for esophagoscopes or gastroscopes, particularly in cases of obscure GI bleeding or small bowel conditions. For instance, according to Medtronic, the market for capsule endoscopy (e.g., PillCam systems) is growing, particularly in regions like North America and Europe. Which hampers the demand for esophagoscopes and gastroscopes.

Segment Analysis

The global esophagoscopes and gastroscopes market is segmented based on product type, usability, application, end-user and region.

Product Type:

The gastroscopes segment is expected to dominate the esophagoscopes and gastroscopes market share

Gastrointestinal diseases, such as gastritis, peptic ulcers, esophageal varices, gastric cancer and gastroesophageal reflux disease (GERD), have become increasingly common globally. The demand for gastroscopic procedures to diagnose and treat these conditions is significantly higher compared to esophageal disorders, making gastroscopes a dominant segment.

For instance, gastric cancer is one of the most prevalent cancers globally. According to the World Health Organization (WHO), there are over 1 million new cases of gastric cancer diagnosed annually, leading to an increase in gastroscopy procedures. The prevalence of GERD is growing, particularly in Western countries, where the condition affects approximately 20% of the population, driving the demand for gastroscopes for diagnosis and management.

The market for gastroscopes is also dominated by established companies, which continually improve the technology and increase adoption. Major manufacturers are focusing on innovative features, such as high-definition imaging, advanced gastrointestinal endoscopy and single-use gastroscopes, further enhancing the segment's growth. Companies like Olympus Corporation, Pentax Medical, and Fujifilm lead the market with advanced gastroscopes that include high-definition imaging technology for better diagnosis.

For instance, in May 2023, Olympus Corporation announced the FDA clearance of the new EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes: the GIF-1100 gastrointestinal videoscope indicated for use within the upper digestive tract and the CF-HQ1100DL/I colonovideoscope indicated for use within lower digestive tract.

Gastroscopes are commonly used for both diagnostic and therapeutic purposes, which increases their usage frequency. They are not only used to examine the upper GI tract, but also for procedures like biopsy, polyp removal, and stent placement, making them indispensable in modern GI practice. Gastroscopy is a standard procedure for diagnosing gastritis, ulcers, and esophageal cancers. The procedure also plays a critical role in endoscopic ultrasound (EUS) for staging cancers, further solidifying its importance in the medical field.

Geographical Analysis

North America is expected to hold a significant position in the esophagoscopes and gastroscopes market share

North America has one of the highest prevalence rates for esophageal and gastrointestinal diseases, which significantly drives the demand for gastroscopic and esophagoscopic procedures. Conditions like GERD (gastroesophageal reflux disease), gastritis, peptic ulcers, esophageal cancers and irritable bowel syndrome (IBS) are increasingly common, leading to higher utilization of diagnostic procedures involving esophagoscopes and gastroscopes.

For instance, according to the National Institute of Health, GERD affects approximately 20% of the U.S. population. This has led to a growing need for gastroscopies for diagnosis and treatment. Esophageal cancer is also prevalent, with the American Cancer Society estimating that in 2025, about 22,070 new esophageal cancer cases diagnosed (17,430 in men and 4,640 in women) and about 16,250 deaths from esophageal cancer (12,940 in men and 3,310 in women). This further contributes to the high demand for gastroscopic procedures for diagnosis and treatment of associated symptoms.

Leading global players such as Olympus, Medtronic, Pentax Medical and Fujifilm have a strong foothold in the North American market, which supports both the supply and adoption of gastroscopes and esophagoscopes. These companies are focused on innovation and meeting the rising demand for advanced imaging systems, robot-assisted surgeries, and disposable endoscopes.

For instance, Olympus Corporation is one of the largest manufacturers of gastroscopes and esophagoscopes, and the company has a significant market share in North America, driven by the growing demand for high-definition, disposable, and minimally invasive technologies. According to the Olympus Corporation, North American market accounts for about 35% of total sales in the GI endoscopy.

Asia-Pacific is growing at the fastest pace in the esophagoscopes and gastroscopes market

Countries in the Asia Pacific are investing heavily in upgrading their healthcare infrastructure, including the adoption of modern medical technologies such as gastroscopes and esophagoscopes. The development of healthcare facilities and endoscopic centers in both urban and rural areas is improving access to endoscopic diagnostic tools including esophagoscopes and gastroscopes.

For instance, in July 2024, FUJIFILM India launched its second-largest endoscopy equipment service center in Mumbai. The center will handle repairs of gastroscopes and high-end processors. The new facility aims to reduce service turnaround times and improve delivery across India.

With the increasing preference for minimally invasive procedures in Asia Pacific, there is a higher demand for gastroscopic and esophagoscopic procedures, as they offer patients faster recovery times, reduced discomfort and fewer risks compared to traditional surgical methods. For instance, single-use gastroscopes are gaining traction in the region, especially in countries like India and China, where there is a rising demand for affordable, effective diagnostic solutions in hospitals and clinics.

Competitive Landscape

The major global players in the esophagoscopes and gastroscopes market include Olympus Corporation, FUJIFILM Holdings Corporation, Ambu A/S, EvoEndo, Inc., EndoMed Systems GmbH, Ottomed Endoscopy, KARL STORZ, Integra LifeSciences Corporation, PENTAX Medical, Erbe Elektromedizin GmbH and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global esophagoscopes and gastroscopes market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures, and 153 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Usability
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Adoption of Disposable Esophagoscopes and Gastroscopes
    • 3.1.2. Restraints
      • 3.1.2.1. Competition from Alternative Diagnostic Technologies
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Esophagoscopes And Gastroscopes Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Esophagoscopes*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 5.2.3. Rigid Esophagoscopes
    • 5.2.4. Flexible Esophagoscopes
    • 5.2.5. Transnasal Esophagoscopes
    • 5.2.6. Fiberoptic Esophagoscopes
  • 5.3. Gastroscopes
    • 5.3.1. Rigid Gastroscopes
    • 5.3.2. Flexible Gastroscopes
    • 5.3.3. Transnasal Gastroscopes
    • 5.3.4. Video Gastroscopes

6. Esophagoscopes And Gastroscopes Market, By Usability

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 6.1.2. Market Attractiveness Index, By Usability
  • 6.2. Disposable*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Reusable

7. Esophagoscopes And Gastroscopes Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Esophageal Disorders*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gastric Disorders
  • 7.4. Esophageal and Gastric Cancer Detection
  • 7.5. Gastric Tissue Biopsy
  • 7.6. Esophageal Stent Procedures
  • 7.7. Others

8. Esophagoscopes And Gastroscopes Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Specialty Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Ambulatory Surgical Centers
  • 8.6. Others

9. Esophagoscopes And Gastroscopes Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usability
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Olympus Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. FUJIFILM Holdings Corporation
  • 11.3. Ambu A/S
  • 11.4. EvoEndo, Inc.
  • 11.5. EndoMed Systems GmbH
  • 11.6. Ottomed Endoscopy
  • 11.7. KARL STORZ
  • 11.8. Integra LifeSciences Corporation
  • 11.9. PENTAX Medical
  • 11.10. Erbe Elektromedizin GmbH

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us